First Time Loading...

Pacific Edge Ltd
NZX:PEB

Watchlist Manager
Pacific Edge Ltd Logo
Pacific Edge Ltd
NZX:PEB
Watchlist
Price: 0.084 NZD 1.2% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

PEB's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Pacific Edge Ltd. engages in the discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer. [ Read More ]

The intrinsic value of one PEB stock under the Base Case scenario is 0.668 NZD. Compared to the current market price of 0.084 NZD, Pacific Edge Ltd is Undervalued by 87%.

Key Points:
PEB Intrinsic Value
Base Case
0.668 NZD
Undervaluation 87%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Pacific Edge Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PEB stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Pacific Edge Ltd

Provide an overview of the primary business activities
of Pacific Edge Ltd.

What unique competitive advantages
does Pacific Edge Ltd hold over its rivals?

What risks and challenges
does Pacific Edge Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Pacific Edge Ltd.

Provide P/S
for Pacific Edge Ltd.

Provide P/E
for Pacific Edge Ltd.

Provide P/OCF
for Pacific Edge Ltd.

Provide P/FCFE
for Pacific Edge Ltd.

Provide P/B
for Pacific Edge Ltd.

Provide EV/S
for Pacific Edge Ltd.

Provide EV/GP
for Pacific Edge Ltd.

Provide EV/EBITDA
for Pacific Edge Ltd.

Provide EV/EBIT
for Pacific Edge Ltd.

Provide EV/OCF
for Pacific Edge Ltd.

Provide EV/FCFF
for Pacific Edge Ltd.

Provide EV/IC
for Pacific Edge Ltd.

Show me price targets
for Pacific Edge Ltd made by professional analysts.

What are the Revenue projections
for Pacific Edge Ltd?

How accurate were the past Revenue estimates
for Pacific Edge Ltd?

What are the Net Income projections
for Pacific Edge Ltd?

How accurate were the past Net Income estimates
for Pacific Edge Ltd?

What are the EPS projections
for Pacific Edge Ltd?

How accurate were the past EPS estimates
for Pacific Edge Ltd?

What are the EBIT projections
for Pacific Edge Ltd?

How accurate were the past EBIT estimates
for Pacific Edge Ltd?

Compare the revenue forecasts
for Pacific Edge Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Pacific Edge Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Pacific Edge Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Pacific Edge Ltd compared to its peers.

Compare the P/E ratios
of Pacific Edge Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Pacific Edge Ltd with its peers.

Analyze the financial leverage
of Pacific Edge Ltd compared to its main competitors.

Show all profitability ratios
for Pacific Edge Ltd.

Provide ROE
for Pacific Edge Ltd.

Provide ROA
for Pacific Edge Ltd.

Provide ROIC
for Pacific Edge Ltd.

Provide ROCE
for Pacific Edge Ltd.

Provide Gross Margin
for Pacific Edge Ltd.

Provide Operating Margin
for Pacific Edge Ltd.

Provide Net Margin
for Pacific Edge Ltd.

Provide FCF Margin
for Pacific Edge Ltd.

Show all solvency ratios
for Pacific Edge Ltd.

Provide D/E Ratio
for Pacific Edge Ltd.

Provide D/A Ratio
for Pacific Edge Ltd.

Provide Interest Coverage Ratio
for Pacific Edge Ltd.

Provide Altman Z-Score Ratio
for Pacific Edge Ltd.

Provide Quick Ratio
for Pacific Edge Ltd.

Provide Current Ratio
for Pacific Edge Ltd.

Provide Cash Ratio
for Pacific Edge Ltd.

What is the historical Revenue growth
over the last 5 years for Pacific Edge Ltd?

What is the historical Net Income growth
over the last 5 years for Pacific Edge Ltd?

What is the current Free Cash Flow
of Pacific Edge Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Pacific Edge Ltd.

Financials

Balance Sheet Decomposition
Pacific Edge Ltd

Current Assets 70.8m
Cash & Short-Term Investments 62.2m
Receivables 5.2m
Other Current Assets 3.4m
Non-Current Assets 5.5m
PP&E 4.3m
Intangibles 1.2m
Current Liabilities 7.1m
Accounts Payable 6.5m
Other Current Liabilities 529k
Non-Current Liabilities 884k
Long-Term Debt 884k
Efficiency

Earnings Waterfall
Pacific Edge Ltd

Revenue
24m NZD
Operating Expenses
-59.2m NZD
Operating Income
-35.2m NZD
Other Expenses
3.6m NZD
Net Income
-31.6m NZD

Free Cash Flow Analysis
Pacific Edge Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

PEB Profitability Score
Profitability Due Diligence

Pacific Edge Ltd's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
ROE is Increasing
ROIC is Increasing
Exceptional 1-Year Revenue Growth
32/100
Profitability
Score

Pacific Edge Ltd's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

PEB Solvency Score
Solvency Due Diligence

Pacific Edge Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
76/100
Solvency
Score

Pacific Edge Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PEB Price Targets Summary
Pacific Edge Ltd

Wall Street analysts forecast PEB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PEB is 0.153 NZD with a low forecast of 0.131 NZD and a high forecast of 0.168 NZD.

Lowest
Price Target
0.131 NZD
56% Upside
Average
Price Target
0.153 NZD
82% Upside
Highest
Price Target
0.168 NZD
100% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

PEB Price
Pacific Edge Ltd

1M 1M
+0%
6M 6M
-16%
1Y 1Y
-83%
3Y 3Y
-93%
5Y 5Y
-70%
10Y 10Y
-92%
Annual Price Range
0.084
52w Low
0.072
52w High
0.495
Price Metrics
Average Annual Return 188.23%
Standard Deviation of Annual Returns 448.5%
Max Drawdown -95%
Shares Statistics
Market Capitalization 68.1m NZD
Shares Outstanding 811 271 000
Percentage of Shares Shorted
N/A

PEB Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Pacific Edge Ltd Logo
Pacific Edge Ltd

Country

New Zealand

Industry

Biotechnology

Market Cap

68.1m NZD

Dividend Yield

0%

Description

Pacific Edge Ltd. engages in the discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer. The firm develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers. The firm's segments include NZ Laboratory, US Laboratory and Research NZ & Australia. Its segments are engaged in the research and development of diagnostic and prognostic products for human cancer both in New Zealand and Australia, and operation of the laboratories used for the detection of bladder cancer in the United States and New Zealand. The company offers Cxbladder, which is a suite of non-invasive laboratory tests for the detection and the management of bladder cancer. Cxbladder includes a suite of urine-based molecular tests to determine the likelihood of bladder cancer in patients presenting with hematuria. Its pipeline includes Cxcolorectal, which is a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer, enabling prediction of aggressiveness of the tumor.

Contact

DUNEDIN
Centre for Innovation 87 St David St, PO Box 56
+6434795800.0
https://www.pacificedgedx.com

IPO

2003-02-12

Employees

-

Officers

Chief Executive Officer
Dr. Peter Meintjes
Chief Financial Officer
Mr. Grant Gibson
Chief Operating Officer
Mr. Darrell Morgan
Chief Technology Officer
Dr. Justin Harvey
Chief Scientific Officer & Member of Scientific Advisory Board
Prof. Parry Guilford Ph.D.
Senior Vice President of Sales - Pacific Edge Diagnostics USA Limited
Mr. Jack Atchason
Show More
Chief Digital Officer
Mr. Andrew McIntosh
President of Asia Pacific
Glen Costin
Chief Medical Officer
Dr. Tamer Aboushwareb
Executive Chairman & President of Pacific Edge Diagnostics USA
Mr. David Levison
Show Less

See Also

Discover More
What is the Intrinsic Value of one PEB stock?

The intrinsic value of one PEB stock under the Base Case scenario is 0.668 NZD.

Is PEB stock undervalued or overvalued?

Compared to the current market price of 0.084 NZD, Pacific Edge Ltd is Undervalued by 87%.